共 12 条
[1]
[2]
RETRACTED: Tanshinone IIA alleviates oxidative damage after spinal cord injury in vitro and in vivo through up-regulating miR-124.[J].Gu Gong;Yiqi Gu;Yunfeng Zhang;Wanguo Liu;Li Li;Juan Li.Life Sciences.2019,
[3]
Leukocyte immunoglobulin-like receptor B4 (LILRB4) negatively mediates the pathological cardiac hypertrophy by suppressing fibrosis; inflammation and apoptosis via the activation of NF-κB signaling.[J].Quanzheng Li;Gongchang Wei;Tao Tao.Biochemical and Biophysical Research Communicatio.2018,
[4]
Tanshinone IIA promotes IL2-mediated SW480 colorectal cancer cell apoptosis by triggering INF2-related mitochondrial fission and activating the Mst1-Hippo pathway.[J].Jun Qian;Dong Fang;Hong Lu;Yi Cao;Ji Zhang;Rong Ding;Lingchang Li;Jiege Huo.Biomedicine & Pharmacotherapy.2018,
[5]
Tanshinone IIA ameliorates lipopolysaccharide-induced inflammatory response in bronchial epithelium cell line BEAS-2B by down-regulating miR-27a.[J].Xiuxia Liu;Jie Meng.Biomedicine & Pharmacotherapy.2018,
[7]
Tanshinone IIA ameliorated endothelial dysfunction in rats with chronic intermittent hypoxia.[J].Lingling Chen;Qiu-Hong Guo;Yue Chang;Ya-Shuo Zhao;Ai-Ying Li;En-Sheng Ji.Cardiovascular Pathology.2017,
[8]
Reduction of atrial fibrillation by Tanshinone IIA in chronic heart failure.[J].Zhifeng He;Changzheng Sun;Yi Xu;Dezhi Cheng.Biomedicine & Pharmacotherapy.2016,

